NCT00630682

A Pilot Trial of Dextroamphetamine for Methamphetamine Dependence

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: California Pacific Medical Center Research Institute · Academic / Other
• Sex: All
• Age: 18 Years – 50 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to assess the safety and effectiveness dextroamphetamine to help methamphetamine users quit or cut down on their use. The study lasts for 9 weeks. Eligible participants will attend research visits twice per week, and will receive individual counseling sessions once per week for all 9 weeks. 50% of the participants will receive the active medication while the other 50% will receive the placebo (sugar pill). Neither the participant or the study team will know if the participant is receiving the placebo or active drug.

Conditions

• Methamphetamine Addiction

Interventions

Type	Name	Description
DRUG	Dextroamphetamine	1 week placebo and 8 weeks 60mg d-AMP QD.
DRUG	Placebo	9 weeks of placebo 60mg capsules QD.

Timeline

• Start date: 2006-09-01
• Primary completion: 2009-03-01
• Completion: 2011-08-01
• First posted: 2008-03-07
• Last updated: 2013-06-03

Locations

1 site across 1 country: United States